Test Price
2,800 AEDโ Home Collection Available
SLC6A9 Gene Glycine Encephalopathy with Normal Serum Glycine Genetic Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Post-test result interpretation by DHA-licensed Consultant Medical Genetics via telephonic consultation.
Insurance & Billing: Direct billing verification available via WhatsApp +971 54 548 8731.
Price: 2,800 AED โ inclusive of genetic counselling review and comprehensive molecular report.
Test Overview & Methodology
This next-generation sequencing (NGS) genetic test provides definitive molecular confirmation of SLC6A9-related glycine encephalopathy with normal serum glycine. The analysis is essential for targeted clinical management, family risk assessment, and genetic counselling. Unlike biochemical assays that only measure glycine levels, our NGS approach identifies pathogenic variants directly, enabling a precise molecular diagnosis even when serum glycine remains within normal limits.
| Parameter | Our Test (NGS) | Closest Alternative (Serum Glycine / CSF Analysis) |
|---|---|---|
| Analytical Sensitivity | >99% | Cannot detect SLC6A9 variants |
| Turnaround Time | 3โ4 Weeks | 24โ72 hours, non-diagnostic |
| Clinical Utility | Definitive molecular diagnosis | Excludes classic NKH only |
Referral Pathways & Pre-Test Preparation
Three Referral Pathways:
- General Physician / Primary Care Doctor โ first clinical suspicion, initial workup, and referral for genetic testing.
- Clinical Geneticist โ variant interpretation, pedigree analysis, and family risk counselling.
- Neurologist โ neurodevelopmental assessment, seizure management, and encephalopathy treatment planning.
Pre-Test Requirements: Provide a complete clinical history. A genetic counselling session is strongly recommended to document a three-generation pedigree of affected family members. Sample can be collected as whole blood, extracted DNA, or one drop of blood on an FTA card. No fasting or medication changes are required unless directed by your doctor. Do not collect during acute febrile illness.
Physician Insight & Safety Protocols
โMolecular confirmation of glycine encephalopathy with normal serum glycine through SLC6A9 sequencing provides critical clarity for families and clinicians. However, a negative result does not rule out all metabolic or genetic etiologies. Always correlate the genetic finding with the full clinical picture and seek integrated care from a clinical geneticist or neurologist for comprehensive management.โ
Advisory: Medication & Clinical Precautions
โ ๏ธ Important Clinical Advisory
Do not discontinue, alter, or adjust any prescribed medication without explicit guidance from your treating physician. This test is a diagnostic aid and does not replace ongoing medical supervision or emergency care protocols.
Exclusion Criteria & Emergency Red Flags
Contraindications for Sample Collection
- Active high fever or acute infection (postpone collection until resolved).
- Inability to provide informed consent or absence of legal guardian consent for minors.
- Recent traumatic brain injury or severe metabolic decompensation.
- Seek emergency care immediately if: new-onset seizures, sudden loss of consciousness, or severe respiratory distress occur before or after testing.
Patient FAQ & Clinical Guidance
1. What does the SLC6A9 gene test detect?
This test identifies disease-causing variants in the SLC6A9 gene linked to glycine encephalopathy with normal blood glycine levels. A positive result guides precise treatment planning, surveillance, and genetic counselling for at-risk family members.
2. Is the test suitable for children and newborns?
Yes, the test can be performed on children under parental or legal guardian consent using a small blood sample or a single drop on an FTA card. The same NGS workflow is used regardless of patient age.
3. How do I arrange home sample collection and insurance approval?
Contact our team via WhatsApp at +971 54 548 8731 to schedule VIP mobile phlebotomy. Our administrative team will verify direct billing with your insurance provider before the visit to ensure a seamless experience.
4. What is the turnaround time for results?
The standard turnaround time is 3โ4 weeks from sample receipt at our laboratory. This accounts for DNA extraction, library preparation, NGS sequencing, bioinformatic analysis, variant interpretation, and clinical report generation.
5. Will my insurance cover the cost of the test?
Coverage varies by insurance provider and policy. Our team can verify your direct billing eligibility before sample collection. Please share your insurance details via WhatsApp for a pre-authorisation check.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection Framework
DNA Labs UAE operates under the regulatory oversight of the Dubai Healthcare City Authority and complies with all applicable federal laws governing clinical testing and patient data privacy.
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ governs the lawful collection, processing, and storage of personal health data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ regulates the secure handling of electronic health records and telemedicine platforms.
- Federal Decree-Law No. 4 of 2016 on Medical Liability โ defines standards for clinical testing safety, patient consent, and professional accountability.
- ISO 9001:2015 Certification โ quality management system audited and accredited for laboratory processes.
Clinical & Logistical Metadata
| Test Name | SLC6A9 Gene Glycine Encephalopathy with Normal Serum Glycine Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card (dried blood spot) |
| Methodology Used | Next-Generation Sequencing (NGS) โ full gene mutation analysis |
| ICD-10-CM Code | E72.8, G93.49, Z13.71 |
| LOINC Code | 82939-0 (SLC6A9 gene full mutation analysis) |
| DHA Facility License & Address | License No. 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians